Vimarsana
Biggest News Aggregation in the World

Page 5 - Precision Flow Plus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precision Flow Plus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precision Flow Plus Today - Breaking & Trending Today

Vapotherm, Inc. (VAPO) CEO Joseph Army on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Vapotherm, Inc. (VAPO) CEO Joseph Army on Q1 2022 Results - Earnings Call Transcript

Vapotherm, Inc. (NYSE:NYSE:VAPO) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Mark Klausner - Westwicke Partners Joseph Army - CEO, President & Director...

Vapotherm (NYSE:VAPO) Upgraded to Buy by Zacks Investment Research - Vimarsana News

Vapotherm (NYSE:VAPO) Upgraded to Buy by Zacks Investment Research

Zacks Investment Research upgraded shares of Vapotherm (NYSE:VAPO – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday, Zacks.com reports. They currently have $5.25 price target on the stock. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for […]

Vapotherm (VAPO) Set to Announce Earnings on Wednesday - Vimarsana News

Vapotherm (VAPO) Set to Announce Earnings on Wednesday

Vapotherm (NYSE:VAPO – Get Rating) is set to post its quarterly earnings results after the market closes on Wednesday, May 4th. Analysts expect the company to announce earnings of ($0.63) per share for the quarter. Vapotherm has set its FY 2022 guidance at EPS.Persons that are interested in participating in the company’s earnings conference call […]

Vapotherm (VAPO) – Analysts' Weekly Ratings Changes - Vimarsana News

Vapotherm (VAPO) – Analysts' Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of Vapotherm (NYSE: VAPO) recently: 4/23/2022 – Vapotherm was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the […]

Vapotherm (NYSE:VAPO) Upgraded by Zacks Investment Research to "Hold" - Vimarsana News

Vapotherm (NYSE:VAPO) Upgraded by Zacks Investment Research to "Hold"

Vapotherm (NYSE:VAPO – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing […]